0.05
+12.50%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medx Health
Its shares trade on TSX Venture under the ticker MDX.V. It has been listed since 12 February 2008. In the fiscal year to 31 December 2025, it reported revenue of C$473,266 and a net loss of C$6.3m. At that date it held total assets of C$702,332 and shareholders' equity of −C$9.7m.
MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. The company is headquartered in Mississauga, Ontario. The company went IPO on 2008-02-12. The company develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. The company focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 12 Feb 2008
- Website
- medxhealth.com ↗
Leadership
Pay as last reported
- Mr. Kenneth McKayIndependent Chairman of the Board
- Mr. Stephen LockyerPresident, Director, since 2023C$112,123
- Mr. John GevisserChief Executive Officer
- Mr. David HennigarIndependent Vice Chairman of the Board
- Mr. Christopher FreemanActing Chief Financial Officer, SecretaryC$6,727
- Mr. Michael DruhanPresident - Dermatological Services and ProductsC$284,849
- Mr. Edmund HoIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medx Health Corp develops and manufactures skin-related screening tools and phototherapy devices.
- The company focuses on skin health with its SIAscopy technology and DermSecure telemedicine platform.
- Products like SIAMETRICS, SIMSYS, and MoleMate use non-invasive light-based technology for skin lesion scanning.
Weaknesses
- The company's products are limited to skin health applications and phototherapy devices.
- The company has a narrow focus on skin-related medical devices and software.
- The company's technology is specific to skin lesion scanning and pain relief treatments.
Opportunities
- Expanding the use of SIAscopy technology beyond skin health applications could open new markets.
- Growing demand for telemedicine platforms could increase adoption of DermSecure.
- Potential for developing new phototherapy devices for additional medical conditions.
Threats
- Competition from other medical device manufacturers in the skin health sector.
- Regulatory changes could impact the approval and sale of medical devices.
- Dependence on a single market segment (skin health) may limit growth opportunities.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.